Sapporo Clinical Laboratory
9776.T
Financials · Consolidated
| Fiscal year ended | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 | 2020-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥20.1bn | ¥19.7bn | ¥20.1bn | ¥19.1bn | ¥17.5bn | ¥17.7bn |
| Operating income | ¥706m | ¥535m | ¥1.0bn | ¥1.5bn | ¥1.1bn | — |
| Ordinary income | ¥708m | ¥515m | ¥1.2bn | ¥1.6bn | ¥1.2bn | ¥983m |
| Net income (owners) | ¥464m | ¥380m | ¥569m | ¥1.0bn | ¥794m | ¥528m |
| Total assets | ¥16.5bn | ¥16.7bn | ¥16.5bn | ¥16.1bn | ¥14.5bn | ¥11.6bn |
| Net assets / equity | ¥11.4bn | ¥11.2bn | ¥10.9bn | ¥10.3bn | ¥9.3bn | ¥8.5bn |
| Operating cash flow | ¥731m | ¥1.1bn | ¥1.4bn | ¥1.6bn | ¥838m | ¥1.3bn |
| EPS (basic) | ¥148.35 | ¥114.14 | ¥170.53 | ¥306.16 | ¥231.85 | ¥154.3 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 67 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2025-03
| Segment | External sales | Profit |
|---|---|---|
| Clinical Testing Business | ¥7.8bn | ¥255m |
| Dispensing Pharmacy Business | ¥11.3bn | ¥742m |
| Medical Devices Sales And Maintenance Business | ¥874m | −¥4m |
| Other segments | ¥166m | ¥125m |
| Total | ¥20.0bn | ¥993m |
| Total | ¥20.1bn | ¥1.1bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.